126 related articles for article (PubMed ID: 37439379)
1. Surgery-ineligible elderly patients with cutaneous squamous cell carcinoma of the head and neck region gain clinical benefit from definitive weekly hypofractionated radiotherapy.
De Felice F; Serpone M; Cattaneo CG; Di Giammarco F; Fallico A; Delle Donne A; Lanzilao M; Vitti E; Marampon F; Musio D; Tombolini V; Minniti G
Head Neck; 2023 Sep; 45(9):2363-2368. PubMed ID: 37439379
[TBL] [Abstract][Full Text] [Related]
2. Definitive weekly hypofractionated radiotherapy in surgery-ineligible older adults with cutaneous squamous cell carcinoma of the head and neck region.
De Felice F; Serpone M; Cattaneo CG; Di Giammarco F; Fallico A; Delle Donne A; Lanzilao M; Vitti E; Marampon F; Musio D; Tombolini V; Minniti G
J Geriatr Oncol; 2024 Jan; 15(1):101596. PubMed ID: 37517887
[TBL] [Abstract][Full Text] [Related]
3. Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region.
De Felice F; Musio D; Tombolini V
Radiol Med; 2021 Apr; 126(4):620-622. PubMed ID: 33058025
[TBL] [Abstract][Full Text] [Related]
4. Definitive weekly hypofractionated radiotherapy in cutaneous squamous cell carcinoma: response rates and outcomes in elderly patients unfit for surgery.
De Felice F; Musio D; De Falco D; Grapulin L; Magnante AL; Caiazzo R; Bulzonetti N; Tombolini V
Int J Dermatol; 2022 Aug; 61(8):911-915. PubMed ID: 34817875
[TBL] [Abstract][Full Text] [Related]
5. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
[TBL] [Abstract][Full Text] [Related]
6. Moderately Hypofractionated Radiotherapy Without Chemotherapy in Elderly or Frail Patients With Head and Neck Cancer.
Fryen A; Brandes I; Wichmann J; Christiansen H; Tavassol F; Durisin M; Merten R
In Vivo; 2022; 36(3):1259-1266. PubMed ID: 35478110
[TBL] [Abstract][Full Text] [Related]
7. HYPORT: Phase 1 Study of 3-Week Hypofractionated Postoperative Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
Moon DH; Avkshtol V; Vo D; Ahn C; Sumer B; Day AT; Tillman B; Myers L; Truelson J; Sher DJ
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):157-164. PubMed ID: 37380084
[TBL] [Abstract][Full Text] [Related]
8. Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?
Bonomo P; Desideri I; Loi M; Lo Russo M; Olmetto E; Maragna V; Francolini G; Delli Paoli C; Grassi R; Pezzulla D; Greto D; Meattini I; Livi L
Oral Oncol; 2017 Nov; 74():142-147. PubMed ID: 29103743
[TBL] [Abstract][Full Text] [Related]
9. Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study.
Martínez-Trufero J; Lozano Borbalas A; Pajares Bernad I; Taberna Sanz M; Ortega Izquierdo E; Cirauqui Cirauqui B; Rubió-Casadevall J; Plana Serrahima M; Ponce Ortega JM; Planas Toledano I; Caballero J; Marruecos Querol J; Iglesias Docampo L; Lambea Sorrosal J; Adansa JC; Mesía Nin R;
Clin Transl Oncol; 2021 Aug; 23(8):1666-1677. PubMed ID: 33876416
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma.
De Felice F; Vetrone L; Bulzonetti N; Caiazzo R; Marampon F; Musio D; Tombolini V
Med Oncol; 2019 Jun; 36(8):68. PubMed ID: 31190132
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
13. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
[TBL] [Abstract][Full Text] [Related]
14. Role of hypofractionated palliative radiotherapy in patients with stage four head-and-neck squamous cell carcinoma.
Mudgal A; Arya AK; Yadav I; Chaudhary S
J Cancer Res Ther; 2019; 15(3):528-532. PubMed ID: 31169215
[TBL] [Abstract][Full Text] [Related]
15. Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
Szturz P; Wouters K; Kiyota N; Tahara M; Prabhash K; Noronha V; Castro A; Licitra L; Adelstein D; Vermorken JB
Oncologist; 2017 Sep; 22(9):1056-1066. PubMed ID: 28533474
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
[TBL] [Abstract][Full Text] [Related]
18. Individualized treatment of head neck squamous cell carcinoma patients aged 70 or older with radiotherapy alone or associated to cisplatin or cetuximab: impact of weekly radiation dose on loco-regional control.
Belgioia L; Bacigalupo A; Missale F; Vecchio S; Chiola I; Callegari S; Verzanini E; Peretti G; Corvò R
Med Oncol; 2019 Mar; 36(5):42. PubMed ID: 30927146
[TBL] [Abstract][Full Text] [Related]
19. Mono- and Bi-weekly Hypofractionated Radiation Therapy for the Treatment of Epithelial Skin Cancer in Very Elderly Patients.
Valeriani M; Nicosia L; Agolli L; Reverberi C; Galvagno E; DE Sanctis V; Minniti G; Carlesimo M; Osti MF
Anticancer Res; 2017 Feb; 37(2):825-830. PubMed ID: 28179337
[TBL] [Abstract][Full Text] [Related]
20. The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.
Kancherla KN; Oksuz DC; Prestwich RJ; Fosker C; Dyker KE; Coyle CC; Sen M
Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):141-8. PubMed ID: 20934860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
